FDA’s FY22 budget priorities: boost inspections, surveillance; avert device shortages

FDA’s FY22 budget priorities: boost inspections, surveillance; avert device shortages

Source: 
RAPS.org
snippet: 

The US Food and Drug Administration’s FY 2022 budget request to Congress indicates the agency’s wishes to catch up on the backlog of inspections that have been delayed due to COVID-19, improve its drug surveillance efforts to detect possible shortages, and avert shortages for such medical devices as personal protective equipment (PPE).